Psoriasis: open trials in Argentina

• NCT06663332

  A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

  Trial Treatment · Phase 3 · Janssen Research & Development, LLC

  Instituto CAICI, Rosario

  Registry updated 2026-11-03

• NCT07116967

  Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

  Trial Treatment · Phase 3 · Bristol-Myers Squibb

  Derma Internacional S.A., Autonomous City of Buenos Aires · Buenos Aires Skin S.A, Buenos Aires · Instituto de Neumonologia y Dermatologia, Buenos Aires · Hospital de Clinicas Jose de San Martin, Buenos Aires · Local Institution - 0429, Buenos Aires · CONEXA Investigacion Clinica S.A., Buenos Aires · Consultorios Reumatológicos Pampa, C.a.b.a. · Hospital Italiano de Buenos Aires, CABA · Psoriahue, Ciudad Autonoma Buenos Aires · STAT Research S.A., Ciudad Autonoma Buenos Aires · CEMEDIAB - Centro Medico Diabetologico, Ciudad Autónoma Buenos Aires · Instituto de Investigaciones Clinicas Cordoba S.A., Córdoba · Viviana Parra Instituto Parra Dermatología, Mendoza

  Registry updated 2026-10-28

• NCT06979453

  A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

  Trial Treatment · Phase 3 · Bristol-Myers Squibb

  Hospital de Niños Dr. Ricardo Gutiérrez, Buenos Aires · Derma Internacional, Buenos Aires · Hospital Italiano de Buenos Aires, Buenos Aires · CONEXA Investigacion Clinica S.A., Buenos Aires · Psoriahue, Ciudad Autonoma de Buenos Aires · Instituto de Neumonologia Y Dermatologia, Ciudad Autonoma de Buenos Aires · Centro de Investigaciones Médicas Tucuman, SAN M. de Tucuman

  Registry updated 2026-10-27

• NCT04772079

  A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis

  Trial Treatment · Phase 3 · Bristol-Myers Squibb

  Centro de Investigaciones Metabólicas (CINME), Buenos Aires · CONEXA Investigacion Clinica S.A., Buenos Aires · Hospital Italiano de Buenos Aires, CABA · Psoriahue, Ciudad Autonoma de Buenos Aires · Instituto de Neumonologia Y Dermatologia, Ciudad Autonoma de Buenos Aires · Consultora Integral de Salud, Córdoba

  Registry updated 2026-10-26

• NCT06764693

  An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis

  Research · AbbVie

  Cer Instituto Médico /ID# 274445, Quilmes · Instituto Médico Río Cuarto /ID# 274421, Río Cuarto · Instituto Medico de Alta Complejidad San Isidro S.A. /ID# 274417, San Isidro

  Registry updated 2026-02-17

All Psoriasis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error